Depression and Suicide Risk in Mild Cognitive Impairmentthe Role of Alzheimer’s Disease Biomarkers

Referencias bibliográficas

• Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., Snyder, P. J., Carrillo, M. C., Thies, B., & Phelps, C. H. (2011). The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & dementia: the journal of the Alzheimer’s Association, 7(3), 270–279. https://doi.org/10.1016/j.jalz.2011.03.008
• Alejos, M., Vázquez-Bourgon, J., Santurtún, M., Riancho, J., & Santurtún, A. (2020). Do patients diagnosed with a neurological disease present increased risk of suicide? Neurologia, Article S0213-4853(20)30129-8. https://doi.org/10.1016/j.nrl.2020.03.003
• Alphs, L., Brashear, H. R., Chappell, P., Conwell, Y., Dubrava, S., Khin, N. A., Kozauer, N., Hartley, D. M., Miller, D. S., Schindler, R. J., Siemers, E. R., Stewart, M., & Yaffe, K. (2016). Considerations for the assessment of suicidal ideation and behavior in older adults with cognitive decline and dementia. Alzheimer’s & Dementia, 2(1), 48–59. https://doi.org/10.1016/j.trci.2016.02.00
• Atri, A. (2019). The Alzheimer’s disease clinical spectrum: Diagnosis and management. Medical Clinics, 103(2), 263-293. https://doi.org/10.1016/j.mcna.2018.10.009
• Babulal, G. M., Ghoshal, N., Head, D., Vernon, E. K., Holtzman, D. M., Benzinger, T., Fagan, A. M., Morris, J. C., & Roe, C. M. (2016). Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels. The American Journal of Geriatric Psychiatry, 24(11), 1095–1104. https://doi.org/10.1016/j.jagp.2016.04.004
• Babulal, G. M., Roe, C. M., Stout, S. H., Rajasekar, G., Wisch, J. K., Benzinger, T. L., Morris, J. C., & Ances, B. M. (2020). Depression is Associated with Tau and Not Amyloid Positron Emission Tomography in Cognitively Normal Adults. Journal of Alzheimer’s Disease, 74(4), 1045-1055. https://doi.org/10.3233/JAD-191078
• Banning, L. C., Ramakers, I. H., Deckers, K., Verhey, F. R., & Aalten, P. (2019). Affective symptoms and AT (N) biomarkers in mild cognitive impairment and Alzheimer’s disease: A systematic literature review. Neuroscience & Biobehavioral Reviews, 107, 346-359. https://doi.org/10.1016/j.neubiorev.2019.09.014
• Baquero, M., Blasco, R., Campos-García, A., Garcés, M., Fages, E. M., & Andreu-Català, M. (2004). Descriptive study of behavioural disorders in mild cognitive impairment. Revista de Neurologia, 38(4), 323–326.
• Baquero, M., & Martín, N. (2015). Depressive symptoms in neurodegenerative diseases. World Journal of Clinical Cases, 3(8), 682-693. https://doi.org/10.12998/wjcc.v3.i8.682
• Beekman, A. T., Copeland, J. R., & Prince, M. J. (1999). Review of community prevalence of depression in later life. The British Journal of Psychiatry, 174, 307-311. https://doi.org/10.1192/bjp.174.4.307
• Bhalla, R. K., Butters, M. A., Becker, J. T., Houck, P. R., Snitz, B. E., Lopez, O. L., Aizentein, H. J., Raina, K. D., DeKosky, S. T., & Reynolds III, C. F. (2009). Patterns of mild cognitive impairment after treatment of depression in the elderly. The American Journal of Geriatric Psychiatry, 17(4), 308-316. https://doi.org/10.1097/JGP.0b013e318190b8d8
• Blennow, K., & Zetterberg, H. (2018). Biomarkers for Alzheimer’s disease: current status and prospects for the future. Journal of Internal Medicine, 284(6), 643-663. https://doi.org/10.1111/joim.12816
• Braak, H., Zetterberg, H., Del Tredici, K., & Blennow, K. (2013). Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid. Acta Neuropathologica, 126(5), 631–641. https://doi.org/10.1007/s00401-013-1139-0
• Brink, T. L., Yesavage, J. A., Lum, O., Heersema, P. H., Adey, M., & Rose, T. L. (1982). Screening tests for geriatric depression. Clinical Gerontologist, 1(1), 37-43. https://doi.org/10.1300/J018v01n01_06
• Calderón, D. (2018). Epidemiología de la depresión en el adulto mayor [Epidemiology of depression in the elderly]. Revista Médica Herediana, 29(3), 182-191. https://doi.org/10.20453/rmh.v29i3.3408
• Canevelli, M., Cesari, M., Lucchini, F., Valletta, M., Sabino, M., Lacorte, E., Vanacore, N., & Bruno, G. (2017). Need to recalibrate research outcomes in Alzheimer’s disease: focus on neuropsychiatric symptoms. Journal of the American Geriatrics Society, 65(9), 2071-2073. https://doi.org/10.1111/jgs.14989
• Cheng, S. T., Edwin, C. S., Lee, S. Y., Wong, J. Y., Lau, K. H., Chan, L. K., Chan, H., & Wong, M. W. (2010). The geriatric depression scale as a screening tool for depression and suicide ideation: a replication and extension. The American Journal of Geriatric Psychiatry, 18(3), 256- 265. https://doi.org/10.1097/JGP.0b013e3181bf9edd
• Conde-Sala, J. L., Reñé-Ramírez, R., Turró-Garriga, O., Gascón-Bayarri, J., Campdelacreu-Fumadó, J., Juncadella-Puig, M., Rico-Pons, I., & GarreOlmo, J. (2014). Severity of dementia, anosognosia, and depression in relation to the quality of life of patients with Alzheimer disease: discrepancies between patients and caregivers. The American Journal of Geriatric Psychiatry, 22(2), 138–147. https://doi.org/10.1016/j.jagp.2012.07.00
• Conejero, I., Lopez-Castroman, J., Giner, L., & Baca-Garcia, E. (2016). Sociodemographic antecedent validators of suicidal behavior: a review of recent literature. Current Psychiatry Reports, 18(10), Article 94. https://doi.org/10.1007/s11920-016-0732-z
• Conejero, I., Navucet, S., Keller, J., Olié, E., Courtet, P., & Gabelle, A. (2018a). A complex relationship between suicide, dementia, and amyloid: a narrative review. Frontiers in Neuroscience, 12, Article 371. https://doi.org/10.3389/fnins.2018.00371
• Conejero, I., Olié, E., Courtet, P., & Calati, R. (2018b). Suicide in older adults: current perspectives. Clinical Interventions in Aging, 13, 691– 699. https://doi.org/10.2147/CIA.S130670
• Dafsari, F. S., & Jessen, F. (2020). Depression—an underrecognized target for prevention of dementia in Alzheimer’s disease. Translational Psychiatry, 10(1), Article 160. https://doi.org/1-13, 10.1038/s41398-020-0839-1
• Dean, B., Tsatsanis, A., Lam, L. Q., Scarr, E., & Duce, J. A. (2020). Changes in cortical protein markers of iron transport with gender, major depressive disorder and suicide. The World Journal of Biological Psychiatry, 21(2), 119–126. https://doi.org/10.1080/15622975.2018.1555377
• Desseilles, M., Perroud, N., Guillaume, S., Jaussent, I., Genty, C., Malafosse, A., & Courtet, P. (2012). Is it valid to measure suicidal ideation by depression rating scales?. Journal of Affective Disorders, 136(3), 398- 404. https://doi.org/10.1016/j.jad.2011.11.013
• Ekman, U., Ferreira, D., & Westman, E. (2018). The A/T/N biomarker scheme and patterns of brain atrophy assessed in mild cognitive impairment. Scientific Reports, 8(1), 1-10. https://doi.org/10.1038/s41598-018-26151-8
• Fernández‐San Martín, M. I., Andrade, C., Molina, J., Muñoz, P. E., Carretero, B., Rodríguez, M., & Silva, A. (2002). Validation of the Spanish version of the geriatric depression scale (GDS) in primary care. International Journal of Geriatric Psychiatry, 17(3), 279-287. https://doi.org/10.1002/gps.588
• Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189-198.
• Goñi-Sarriés, A., Blanco, M., Azcárate, L., Peinado, R., & López-Goñi, J.L. (2018). Are previous suicide attempts a risk factor for completed suicide? Psicothema, 30(1), 33-38 https://doi.org/10.7334/psicothema2016.318
• Heisel, M. J., Duberstein, P. R., Lyness, J. M., & Feldman, M. D. (2010). Screening for suicide ideation among older primary care patients. The Journal of the American Board of Family Medicine, 23(2), 260-269. https://doi.org/10.3122/jabfm.2010.02.080163
• Heisel, M. J., Flett, G. L., Duberstein, P. R., & Lyness, J. M. (2005). Does the geriatric depression scale (GDS) distinguish between older adults with high versus low levels of suicidal ideation? The American Journal of Geriatric Psychiatry, 13(10), 876-883. https://doi.org/10.1097/00019442-200510000-00007
• Hussain, M., Kumar, P., Khan, S., Gordon, D. K., & Khan, S. (2020). Similarities Between Depression and Neurodegenerative Diseases: Pathophysiology, Challenges in Diagnosis and Treatment Options. Cureus, 12(11), Article e11613. https://doi.org/10.7759/cureus.11613
• Ismail, Z., Gatchel, J., Bateman, D. R., Barcelos-Ferreira, R., Cantillon, M., Jaeger, J., Donovan, N. J., & Mortby, M. E. (2018). Affective and emotional dysregulation as pre-dementia risk markers: exploring the mild behavioral impairment symptoms of depression, anxiety, irritability, and euphoria. International Psychogeriatrics, 30(2), 185-196. https://doi.org/10.1017/S1041610217001880
• Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Feldman, H. H., Frisoni, G. B., Hampel, H., Jagust, W. J., Johnson, K. A., Knopman, D. S., Petersen, R. C., Scheltens, P., Sperling, R. A., & Dubois, B. (2016). A/T/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology, 87(5), 539-547. https://doi.org/10.1212/WNL.0000000000002923
• Jack, C. R., Jr, Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., Liu, E., Molinuevo, J. L., Montine, T., Phelps, C., Rankin, K. P., Rowe, C. C., Scheltens, P., Siemers, E., Snyder, H. M., & Sperling, R. (2018). NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease. Alzheimer’s & Dementia, 14(4), 535–562. https://doi.org/10.1016/j.jalz.2018.02.018
• Javaherian, K., Newman, B. M., Weng, H., Hassenstab, J., Xiong, C., Coble, D., Fagan, A. M., Benzinger, T., & Morris, J. C. (2019). Examining the complicated relationship between depressive symptoms and cognitive impairment in preclinical Alzheimer disease. Alzheimer Disease & Associated Disorders, 33(1), 15-20. https://doi.org/10.1097/WAD.0000000000000284
• Krell-Roesch, J., Vassilaki, M., Mielke, M. M., Kremers, W. K., Lowe, V. J., Vemuri, P., Machulda, M. M., Christianson, T. J., Syrjanen, J. A., Stokin, G. B., Butler, L. M., Traber, M., Jack, C. R., Knopman, D. S., Roberts, R. O., Petersen, R. C. & Geda, Y. E. (2019). Cortical β-amyloid burden, neuropsychiatric symptoms, and cognitive status: the Mayo Clinic Study of Aging. Translational Psychiatry, 9(1), 1-8. https://doi.org/10.1038/s41398-019-0456-z
• Lai, A. X., Kaup, A. R., Yaffe, K., & Byers, A. L. (2018). High occurrence of psychiatric disorders and suicidal behavior across dementia subtypes. The American Journal of Geriatric Psychiatry, 26(12), 1191-1201. https://doi.org/10.1016/j.jagp.2018.08.012
• Lavretsky, H., Siddarth, P., Kepe, V., Ercoli, L. M., Miller, K. J., Burggren, A. C., Bookheimer, S. Y, Huang, S. C., Barrio, J. R., & Small, G. W. (2009). Depression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults. The American Journal of Geriatric Psychiatry, 17(6), 493-502. https://doi.org/10.1097/JGP.0b013e3181953b82
• Li, N., Chen, G., Zeng, P., Pang, J., Gong, H., Han, Y., Zhang, Y., Zhang, E., Zhang, T., & Zheng, X. (2018). Prevalence and factors associated with mild cognitive impairment among Chinese older adults with depression. Geriatrics Gerontology International, Feb;18(2), 263-268. https://doi.org/10.1111/ggi.13171
• Linnemann, C., & Leyhe, T. (2015). Suicide in the elderly–risk factors and prevention. Therapeutische Umschau. Revue therapeutique, 72(10), 633-636. https://doi.org/10.1024/0040-5930/a000729
• Lopez, O. L., Becker, J. T., Sweet, R. A., Klunk, W., Kaufer, D. I., Saxton, J., Habeych, M., & DeKosky, S. T. (2003). Psychiatric symptoms vary with the severity of dementia in probable Alzheimer’s disease. The Journal of Neuropsychiatry and Clinical Neurosciences, 15(3), 346-353.
• Mahoney, F. I., & Barthel, D. W. (1965). Functional evaluation: the Barthel Index. Maryland State Medical Journal, 14, 61–65.
• Martin, E., & Velayudhan, L. (2020). Neuropsychiatric Symptoms in Mild Cognitive Impairment: A Literature Review. Dementia and Geriatric Cognitive Disorders, 49(2), 146–155. https://doi.org/10.1159/000507078
• McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack Jr, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., Mohs, R. C., Morris, J. C., Rossor, M. N., Scheltens, P., Carrillo, M. C., Thies, B., Weintraub, S., & Phelps, C. H. (2011). The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-€Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia, 7(3), 263-269. https://doi.org/10.1016/j.jalz.2011.03.005
• Ng, K. P., Chiew, H., Rosa-Neto, P., Kandiah, N., Ismail, Z., & Gauthier, S. (2021). Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer’s disease and cognitively unimpaired individuals. Translational Neurodegeneration, 10(1), 1-4. https://doi.org/10.1186/s40035-021-00236-3
• Pérez Rodríguez, S., Marco Salvador, J. H., & García-Alandete, J. (2017). The role of hopelessness and meaning in life in a clinical sample with nonsuicidal self-injury and suicide attempts. Psicothema, 29, 3, 323-328. https://doi.org/10.7334/psicothema2016.284
• Petersen, R. C., Roberts, R. O., Knopman, D. S., Boeve, B. F., Geda, Y. E., Ivnik, R. J., Smith, G. E., & Jack, C. R. (2009). Mild cognitive impairment: ten years later. Archives of Neurology, 66(12), 1447-1455. https://doi.org/10.1001/archneurol.20092
• Pomara, N., Bruno, D., Sarreal, A. S., Hernando, R. T., Nierenberg, J., Petkova, E., Sidtis, J. J., Wisniewski, T. M., Mehta, P. D., Pratico, D., Zetterberg, H., & Blennow, K. (2012). Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder. American Journal of Psychiatry, 169(5), 523- 530. https://doi.org/10.1176/appi.ajp.2011.11081153
• Rao, R., Dening, T., Brayne, C., & Huppert, F. A. (1997). Suicidal thinking in community residents over eighty. International Journal of Geriatric Psychiatry, 12(3), 337-343.
• Sekhon, S., Patel, J., & Sapra, A. (2020). Late Onset Depression. StatPearls Publishing.
• Serafini, G., Calcagno, P., Lester, D., Girardi, P., Amore, M., & Pompili, M. (2016). Suicide risk in Alzheimer’s disease: a systematic review. Current Alzheimer Research, 13(10), 1083-1099. https://doi.org/10.1002/(10.2174/1567205013666160720112608
• Schoonenboom, N. S., Reesink, F. E., Verwey, N. A., Kester, M. I., Teunissen, C. E., van de Ven, P. M., Pijnenburg, Y. A., Blankenstein, M. A., Rozemuller, A. J., Scheltens, P., & van der Flier, W. M. (2012). Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort. Neurology, 78(1), 47–54. https://doi.org/10.1212/WNL.0b013e31823ed0f0
• Showraki, A., Murari, G., Ismail, Z., Barfett, J. J., Fornazzari, L., Munoz, D. G., Schweizer, T. A., & Fischer, C. E. (2019). Cerebrospinal Fluid Correlates of Neuropsychiatric Symptoms in Patients with Alzheimer’s Disease/ Mild Cognitive Impairment: A Systematic Review. Journal of Alzheimer’s Disease, 71(2), 477–501. https://doi.org/10.3233/JAD-190365
• Small, S. A., & Duff, K. (2008). Linking Abeta and tau in late-onset Alzheimer’s disease: a dual pathway hypothesis. Neuron, 60(4), 534– 542. https://doi.org/10.1016/j.neuron.2008.11.007
• Stepién, T., Heitzman, J., Wierzba-Bobrowicz, T., Gosek, P., Krajewski, P., ChrzczonowiczStepién, A., Berent, J., Jurek, T. & Bolechała, F. (2021). Neuropathological Changes in the Brains of Suicide Killers. Biomolecules, 11, Article 1674. https://doi.org/ 10.3390/biom11111674
• Uncapher, H., & Sandberg, D. A. (1998). Using the Geriatric Depression Scale to detect suicidal ideation in inpatient older adults. Journal of Clinical Geropsychology, 4, 349-358.
• Waern, M., Rubenowitz, E., & Wilhelmson, K. (2003). Predictors of suicide in the old elderly. Gerontology, 49(5), 328-334. https://doi.org/10.1159/000071715
• Wenzler, S., Knochel, C., Balaban, C., Kraft, D., Kopf, J., Alves, G. S., Prvulovic, D., Carvalho, A. F., & Oertel-Knochel, V. (2017). Integrated Biomarkers for Depression in Alzheimer’s Disease: A Critical Review. Current Alzheimer Research, 14(4), 441–452. https://doi.org/10.2174/1567205013666160603011256
• Wiels, W., Baeken, C., & Engelborghs, S. (2020). Depressive Symptoms in the Elderly—An Early Symptom of Dementia? A Systematic Review. Frontiers in Pharmacology, 11, Article 34. https://doi.org/10.3389/fphar.2020.00034
• World Health Organization. (2020). Dementia. https://www.who.int/es/news-room/fact-sheets/detail/dementia
• Yesavage, J. A., Brink, T. L., Rose, T. L., Lum, O., Huang, V., Adey, M., & Leirer, O.V. (1982). Development and validation of a geriatric depression scale. Journal of Psychiatric Research, 17, 31-49. https://doi.org/10.1016/0022-3956(82)90033-4
• Yoshida, K., Hata, Y., Ichimata, S., & Nishida, N. (2019). Tau and Amyloid-β Pathology in Japanese Forensic Autopsy Series Under 40 Years of Age: Prevalence and Association with APOE Genotype and Suicide Risk. Journal of Alzheimer’s Disease, 72(2), 641-652. https://doi.org/10.3233/JAD-190196
• Youn, H., Lee, S., Han, C., Kim, S. H., & Jeong, H. G. (2019). Association between brain amyloid accumulation and neuropsychological characteristics in elders with depression and mild cognitive impairment. International Journal of Geriatric Psychiatry, 34(12), 1907-1915. https://doi.org/10.1002/gps.5209
• Zhang, X. X., Tian, Y., Wang, Z. T., Ma, Y. H., Tan, L., & Yu, J. T. (2021). The Epidemiology of Alzheimer’s Disease Modifiable Risk Factors and Prevention. The Journal of Prevention of Alzheimer’s Disease, 8(3), 313-321. https://dx.doi.org/10.14283/jpad.2021.15